Increased serum cortisol binding in chronic active hepatitis-Reference-Cited by-同舟云学术

Increased serum cortisol binding in chronic active hepatitis

Published:1989-01 Issue:1 Volume:86 Page:39-42
ISSN:0002-9343
Container-title:The American Journal of Medicine
language:en
Short-container-title:The American Journal of Medicine

Author:

Orbach Ozzie,Schussler George C.

Publisher

Elsevier BV

Subject

General Medicine

Reference28 articles.

1. Increased serum thyroid hormone binding and decreased free hormone in chronic active liver disease;Schussler;N Engl J Med,1978

2. The association of liver disease with increased thyroid hormone binding during methadone maintenance;Schussler;Am J Drug Alcohol Abuse,1980

3. Relations between serum levels of TSH, TBG, T4, T3 rT3 and various histologically classified chronic liver diseases;L'age;J Endocrinol Invest,1980

4. Serum free thyroid hormone concentrations and indices in alcoholic liver cirrhosis, primary biliary cirrhosis and chronic active hepatitis;Liewendahl;Acta Endocrinol (Copenh),1983

5. An in vivo system for quantification of estrogenicity I. Physiologic changes in the binding capacity of serum corticosteroid globulin;Moore;Am J Obstet Gynecol,1978

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The addition of corticotropin-releasing hormone to 2-day low dose dexamethasone suppression test provides additional case detection;Endocrine;2023-03-14

2. Cortisol: Analytical and clinical determinants;Advances in Clinical Chemistry;2023

3. The Addition of Corticotropin-Releasing Hormone to 2-day Low Dose Dexamethasone Suppression Test Provides Additional Case Detection;2022-12-06

4. Consensus on diagnosis and management of Cushing's disease: a guideline update;The Lancet Diabetes & Endocrinology;2021-12

5. Biochemical diagnosis of Cushing’s disease: Screening and confirmatory testing;Best Practice & Research Clinical Endocrinology & Metabolism;2021-01